Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 72.95
+0.91 (1.26%)
At close: Aug 20, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 16.46 billion as of August 20, 2026. Its market cap has decreased by -20.74% in one year.
Market Cap
16.46B
Enterprise Value
19.70B
Revenue
13.84B
Ranking
n/a
PE Ratio
15.01
Stock Price
72.95
ChartMarket Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 16.46B, an increase of 130.36%. That is a compound annual growth rate of 17.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 16.46B | -14.85% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 109.30B |
| Abbott Laboratories (Pakistan) | 87.80B |
| The Searle Company | 52.66B |
| Highnoon Laboratories | 52.42B |
| AGP Limited | 50.28B |
| Ferozsons Laboratories | 16.08B |
| Macter International | 12.61B |
| Otsuka Pakistan | 4.96B |